Konstanze Diefenbach
Berlin, BE 13353, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects.
Journal: Cancer chemotherapy and pharmacology
Published: September 04, 2017
Pharmacologic activity and pharmacokinetics of metabolites of regorafenib in preclinical models.
Journal: Cancer medicine
Published: April 07, 2016
A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer.
Journal: Cancer chemotherapy and pharmacology
Published: June 10, 2015
Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancers.
Journal: Clinical lung cancer
Published: February 16, 2015
EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation.
Journal: International journal of women's health
Published: April 24, 2013
Bioequivalence evaluation of a folate-supplemented oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium versus ethinylestradiol/drospirenone and levomefolate calcium alone.
Journal: Clinical drug investigation
Published: August 23, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026